NRx Pharmaceuticals Responds
NRx Pharmaceuticals issues statement in response to Kadima allegations, citing arbitration over non-acquisition by HOPE Therapeutics
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.